Phacilitate

  • About Us
    • Advisory Board
  • Insights and Resources
        • All Insights and Resources
          The latest and greatest Insights Phacilitate has to offer, across all our key sectors and mediums

        • Webinar Library
          View upcoming and past webinars about world of advanced therapies

           

          The Phacilitate Podcast
          Insightful conversations with industry leaders

        • Content Services
          We create game-changing content that empowers the advanced therapies industry

          • Industry Insights
            • Clinical Trials
            • Collaborations, Mergers and Acquisitions
            • Finance and Investment
            • GMP
            • Patient Access and Engagement
            • Regulatory and Standards
            • Reimbursement
            • Strategy
          • Manufacturing
            • Automation and Digitisation
            • Characterisation
            • CMC
            • GMP
            • Logistics
            • Partnering
            • Point of Care
            • Raw Materials
            • Scaling Up
            • Skills, Talent and Development
            • Supply Chain
          • Techniques
            • Allogeneic
            • Autologous
            • CAR-X
            • Cell Therapy
            • Gene Editing
            • Gene Therapy
            • NKx
            • Stem Cells
            • Viral/Non-viral Vectors
  • Latest News
  • Events
  • The Directory
  • Membership
    • Phacilitate Network
    • Women in Advanced Therapies
Back
  • About Us
    • Advisory Board
  • Insights and Resources
        • All Insights and Resources
          The latest and greatest Insights Phacilitate has to offer, across all our key sectors and mediums

        • Webinar Library
          View upcoming and past webinars about world of advanced therapies

           

          The Phacilitate Podcast
          Insightful conversations with industry leaders

        • Content Services
          We create game-changing content that empowers the advanced therapies industry

          • Industry Insights
            • Clinical Trials
            • Collaborations, Mergers and Acquisitions
            • Finance and Investment
            • GMP
            • Patient Access and Engagement
            • Regulatory and Standards
            • Reimbursement
            • Strategy
          • Manufacturing
            • Automation and Digitisation
            • Characterisation
            • CMC
            • GMP
            • Logistics
            • Partnering
            • Point of Care
            • Raw Materials
            • Scaling Up
            • Skills, Talent and Development
            • Supply Chain
          • Techniques
            • Allogeneic
            • Autologous
            • CAR-X
            • Cell Therapy
            • Gene Editing
            • Gene Therapy
            • NKx
            • Stem Cells
            • Viral/Non-viral Vectors
  • Latest News
  • Events
  • The Directory
  • Membership
    • Phacilitate Network
    • Women in Advanced Therapies
Join Today
Sign In
Sign In
Join Today
  • All Insights and Resources
  • Industry Insights
  • Manufacturing
  • Techniques
Clinical Trials
Collaborations, Mergers and Acquisitions
Finance and Investment
GMP
Patient Access and Engagement
Regulatory and Standards
Reimbursement
Strategy
Automation and Digitisation
Characterisation
CMC
GMP
Logistics
Partnering
Point of Care
Raw Materials
Scaling Up
Skills, Talent and Development
Supply Chain
Allogeneic
Autologous
CAR-X
Cell Therapy
Gene Editing
Gene Therapy
NKx
Stem Cells
Viral/Non-viral Vectors
All News

CAR-X

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
5 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™
Nexcella Initiates NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Facility
2 June 2023
Nexcella Initiates NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Facility
Nexcella, a subsidiary of Immix
CDMO, uBriGene, Expands to the US Market with Major Acquisition
19 May 2023
CDMO, uBriGene, Expands to the US Market with Major Acquisition
CDMO, uBriGene, Expands to the
Oxford Biomedica Launches Next Generation Lentiviral Vector System: TetraVecta™
18 May 2023
Oxford Biomedica Launches Next Generation Lentiviral Vector System: TetraVecta™
Oxford Biomedica launches TetraVecta™
POPULAR NEWS ITEMS
Image
8 June 2023

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image
7 June 2023

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image
5 June 2023

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

Bristol Myers Squibb’s CAR-T Breyanzi Receives Recommendation for Approval from EMA’s CHMP
4 April 2023
Bristol Myers Squibb’s CAR-T Breyanzi Receives Recommendation for Approval from EMA’s CHMP
Bristol Myers Squibb’s CAR-T Breyanzi
Cabaletta Bio to Commence Trial of CABA-201 for Lupus Treatment After FDA Clearance
4 April 2023
Cabaletta Bio to Commence Trial of CABA-201 for Lupus Treatment After FDA Clearance
Cabaletta Bio, a clinical-stage biotechnology
Sartorius to Acquire Polyplus in a $2.6 Billion Cell and Gene Therapy Expansion
3 April 2023
Sartorius to Acquire Polyplus in a $2.6 Billion Cell and Gene Therapy Expansion
Sartorius to Acquire Polyplus in
Sonoma Biotherapeutics and Regeneron Announce $120M Collaboration for Cell Therapies for Autoimmune Diseases
30 March 2023
Sonoma Biotherapeutics and Regeneron Announce $120M Collaboration for Cell Therapies for Autoimmune Diseases
Clinical-stage biotech company Sonama Biotherapeutics
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

logo_footer
logo_mobile_footer
Company
  • About Us
  • Events
  • Contact Us
Resources
  • Insights and Resources
  • Latest News
  • Phacilitate Podcast
  • Content Services
Network
  • Sign In
  • Join Today
social_icon Linkedin
social_icon Twitter

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

  • Privacy Policy
  • Code of Conduct
  • Terms & Conditions
  • Cookies
Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022